| Literature DB >> 24662036 |
Amit Kumar1, Manisha Vaish2, Rajiv R Ratan3.
Abstract
Huntington's disease (HD) is a signature polyglutamine disorder. An enduring theory of HD pathogenesis has involved dysregulation of transcription. Indeed, transcriptional regulatory proteins can be modulated to overcome cardinal features of HD-modeled mice, and efforts to move these into human studies are ongoing. Here, we discuss a unifying hypothesis emerging from these studies, which is that HD represents the pathological disruption of evolutionarily conserved adaptive gene programs to counteract oxidative stress, mitochondrial dysfunction and accumulation of misfolded proteins. Transcriptional dyshomeostasis of adaptive genes is further exacerbated by repression of genes involved in normal synaptic activity or growth factor signaling.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24662036 PMCID: PMC4082751 DOI: 10.1016/j.drudis.2014.03.016
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851